View in EDS HTML Full Text PDF Full Text

Safety and efficacy of CD19-targeted CAR-T-cell therapy for patients with relapsed or refractory TCF3-PBX1 fusion gene-positive B-ALL.

Saved in:
Bibliographic Details
Title: Safety and efficacy of CD19-targeted CAR-T-cell therapy for patients with relapsed or refractory TCF3-PBX1 fusion gene-positive B-ALL.
Authors: Huang, Can1,2 (AUTHOR), Teng, Yuanyin2,3,4 (AUTHOR), Yang, Tingting2,3,4 (AUTHOR), Zhang, Mingming2,3,4 (AUTHOR), Yu, Yinghui2,3,4 (AUTHOR), Fu, Shan2,3,4 (AUTHOR), Feng, Jingjing2,3,4 (AUTHOR), Huang, He2,3,4 (AUTHOR), Hu, Yongxian2,3,4 (AUTHOR) 1313016@zju.edu.cn
Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10245332
DOI:10.1080/16078454.2025.2550815